openPR Logo
Press release

Investigation announced for Investors in shares of Atreca, Inc. (NASDAQ: BCEL)

03-18-2020 10:52 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Atreca, Inc. (NASDAQ: BCEL) shares over potential securities laws violations by Atreca, Inc.

An investigation for investors in Atreca, Inc. (NASDAQ: BCEL) shares over potential securities laws violations by Atreca, Inc.

An investigation was announced on behalf of investors of Atreca, Inc. (NASDAQ: BCEL) shares over potential securities laws violations by Atreca, Inc.

Investors who purchased shares of Atreca, Inc. (NASDAQ: BCEL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Atreca, Inc. (NASDAQ: BCEL regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Redwood City, CA based Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types.
On or around June 19, 2019, Atreca, Inc. conducted its initial public offering ("IPO"), issuing 7,350,000 shares of common stock priced at $17.00 per share.

Shares of Atreca, Inc. reached as high as $29.35 per share on March 4, 2020.

Theon, on March 11, 2020, Atreca, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2019. Among other results, Atreca, Inc. reported fourth quarter GAAP earnings per share of -$0.72, falling $0.03 short of consensus estimates.

Shares of Atreca, Inc. (NASDAQ: BCEL) declined to as low as $10.88 per share on March 18, 2020.

Those who purchased shares of Atreca, Inc. (NASDAQ: BCEL) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Atreca, Inc. (NASDAQ: BCEL) here

News-ID: 1974431 • Views: 167

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Qurate Retail, Inc. (NASDAQ: …
Qurate Retail, Inc is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Qurate Retail, Inc. (NASDAQ: QRTEA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Qurate Retail, Inc. regarding its business, its prospects and its operations were materially false
Lawsuit filed for Investors in shares of Allakos Inc. (NASDAQ: ALLK)
An investor, who purchased shares of Allakos Inc. (NASDAQ: ALLK), filed a lawsuit over alleged Securities Laws violations by Allakos Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and for certain investors are short and strict deadlines running. Deadline: May 11, 2020. NASDAQ: ALLK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Investors in NASDAQ:LNDC shares over potential Wrong …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors at Landec Corporation. Investors who purchased shares of Landec Corporation (NASDAQ: LNDC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Landec directors breached their fiduciary duties and caused damage to the company and its shareholders. Santa Clara, CA based Landec Corporation, together
Lawsuit filed for Investors in shares of PaySign, Inc. (NASDAQ: PAYS)
An investor, who purchased shares of PaySign, Inc. (NASDAQ: PAYS), filed a lawsuit over alleged Securities Laws violations by PaySign, Inc. Investors in shares of PaySign, Inc. (NASDAQ: PAYS) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 9, 2019, PaySign, Inc lowered its fiscal 2019 revenue guidance to a range of $35 million to $37 million, from prior guidance range of $38 million to $40

All 5 Releases


More Releases for Atreca

Immune Repertoire Sequencing Market Opportunities and Future Growth Outlook 2018 …
Immune repertoire refers to the sub-type proteins an organism’s immune system creates. Immune systems in vertebrates have six key types of proteins namely: immunoglobulin (2) and T cell receptors (4). Immune repertoire sequencing enables researchers and scientist to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy. Download PDF Brochure Of This Research Report
Immune Repertoire Sequencing Market Study and Industry Insights 2026 By Global K …
Immune repertoire refers to the sub-type proteins an organism’s immune system creates. Immune systems in vertebrates have six key types of proteins namely: immunoglobulin (2) and T cell receptors (4). Immune repertoire sequencing enables researchers and scientist to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy. Immune Repertoire Sequencing Market: Drivers Increasing research and
Immune Repertoire Sequencing Market Show Significant Demand; Analysis By Top Pla …
Immune repertoire refers to the sub-type proteins an organism’s immune system creates. Immune systems in vertebrates have six key types of proteins namely: immunoglobulin (2) and T cell receptors (4). Immune repertoire sequencing enables researchers and scientist to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable to biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy. Download PDF Brochure of Research Report @
Immune Repertoire Sequencing Market Explore Future Growth 2018-2026 by Global To …
Coherent Market Insights has announced the addition of the “Immune Repertoire Sequencing Market Size Status and Forecast 2026”, The report classifies the global Immune Repertoire Sequencing Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Immune Repertoire Sequencing Speaker market, analyzes and researches the Immune Repertoire Sequencing Speaker development status and forecast in
Immune Repertoire Sequencing Market Enhancement in Medical Sector 2017 to 2022
Worldwide Market Reports added Latest Research Report titled " Global Immune Repertoire Sequencing Market Size, Status and Forecast 2022 " to its Large Report database. This report studies the global Immune Repertoire Sequencing market, analyzes and researches the Immune Repertoire Sequencing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like ArcherDX, Junom Therapeutics, Roche Holding,
Malaria Diagnosis and Treatment Global Key players- Altimmune Inc, Amura Holding …
Malaria    Overview Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. Treatment includes anti-malarial medicines and healthy lifestyle. Click here for sample